PRODUCT

Introduction to Boryung
caring for people’s health

Main Products

A guide to Boryung’ main
products.

Products

A guide to all
Boryung’s products.

close

R&D

The Boryung Company,
envisioning a world with a
healthy mankind.

R&D Vision·Strategy

Boryung’ goal is to develop
into a global company.

Pipeline

The research team at Boryung
aims to lead the future of the
pharmaceutical industry.

close

Investors

The Boryung Company,
envisioning a world with a
healthy mankind.

Financial Information

You can see Boryung’s financial
information.

Stock Information

You can see Boryung’s stock price
information

close

GLOBAL
BUSINESS

An introduction of
Boryung’ global business.

Introduction

The best global company.

CMO

Introducing BRCMO business

Network

50 markets and 150 partners worldwide.

close

PR

An introduction of Boryung ’ value -
Envisioning a healthy mankind.

Advertising

An introduction of video
and printed advertisements of Boryung.

close

Directions

An introduction of Boryung
Pharmaceutical’ value - Envisioning
a healthy mankind.

Directions

An introduction of video
and printed advertisements of Boryung.

close

Governance

You can check reports such as information on stockholders of Boryung.

  • Company Overview

    Boryung has become a company that contribute to human health over the past 60 years since its establishment in 1957.

    Company overview

    Company overview
    Company name Boryung Coporation CEO Jay Kim (Kim Jung-gyun),
    Daniel Chang (Jang Doo-hyun)
    Established November 11, 1963 Listed (on KOSPI) October 24, 1988
    Industry Pharmaceutical Share capital KRW 34.3 billion (As end of - 2021)
    Base date December Total assets KRW 828.69 billion (As end of - 2021)
    HQ Boryung Building,
    136 Changgyeonggung-ro, Jongno-gu, Seoul, Republic of Korea
    Contact +82-2-708-8000
  • Shareholders

    Boryung will strive to guarantee shareholders rights and build a shareholder-friendly corporate culture.

    Shares Outstanding

    As of December 31, 2021

    Shares Outstanding
    Number of ordinary shares issued (in share) Amount per share Share capital Notes
    Common 68,690,000 KRW 500 KRW 34,345,000,000
    Preferred - - -
    Total 68,690,000 KRW 500 KRW 34,345,000,000

    Treasury Shares

    As of December 31, 2021

    Treasury Shares
    Number of shares Remark
    Common 2,804,290
    Preferred -
    Total 2,804,290 Acquisition of treasury shares by trust contract, etc.

    Shareholder return over the past 5 years

    Based on K-IFRS (Korean International Financial Reporting Standards) consolidated statement

    Dividend status for past 5 years
    The 58th The 57th The 56th The 55th The 54th
    Par value (KRW) 500 500 500 500 2,500
    Profit (KRW 1 million) 43,119 26,860 32,222 20,306 56,478
    (Based on Separate financial statements)
    Profit (KRW 1 million)
    27,120 27,048 34,348 22,902 55,352
    Basic earnings per share (KRW) 689 462 744 544 1,334
    Annualized Payout (KRW 1 million) 6,589 4,511 4,204 2,522 6,800
    Annualized Payout (Shares) - - - - -
    Dividend payout ratio (%) 15.28 16.68 13.05 12.42 12.04
    Cash Dividend yield (%) Common 0.7 0.5 0.7 0.6 1.9
    Preferred - - - - -
    Share Dividend yield (%) Common - - - - -
    Preferred - - - - -
    Dividend per share (KRW) Common 100 100 100 60 800
    Preferred - - - - -
    Dividend per share (Shares) Common - - - - -
    Preferred - - - - -

    Shareholder Structure

    The largest shareholders and related parties

    As of December 31, 2021

    The largest shareholders and related parties
    Shareholder Relationship Number of shares owned and ownership percentage
    Beginning of term End of term
    Number of shares Ownership (%) Number of shares Ownership (%)
    Boryung Holdings Co., Ltd. Oneself Common 18,542,523 38.94 25,484,748 37.1
    Kim Seung-ho Executive Director of the affiliates Common 296,692 0.62 0 0
    Kim Eun-seon Executive Director Common 5,412,040 11.37 7,142,296 10.4
    Jay Kim
    (Kim Jung-gyun)
    Executive Director Common 619,520 1.3 817,583 1.19
    Medience Co., Ltd. Affiliates Common 2,305,502 4.84 3,042,582 4.43
    Boryung Jungbo Foundation Foundation Common 60,715 0.13 471,670 0.69
    Total Common 27,236,992 57.2 36,958,879 53.81

    Minority Shareholders

    As of December 31, 2021

    Minority Shareholders
    Number of shareholders Percentage Number of shares Percentage Remark
    Minority Shareholders 37,046 99.92% 23,796,157 34.64% -

    Result of Annual General Shareholders Meeting

    Result of Annual General Shareholders Meeting
    The 56th (FY 2019) The 57th (FY 2020) The 58th (FY 2021)
    Total number of the common shares 44,200,000 47,620,000 68,690,000
    Total number of the common shares with voting rights 42,040,090 45,110,967 65,885,710
    Shares present 27,475,867 31,186,242 44,605,096
    Attendance rate 65.4% 69.1% 67.7%
    The largest shareholders and related parties 23,316,182 27,236,992 36,958,879
    Attendance rate excluding the largest shareholder and related parties 22.2% 22.1% 26.4%
    Agenda Agenda No.1:
    Approval of financial statements
    Agree 97.5%,
    Disagree 2.5%
    Agenda No.1:
    Approval of financial statements
    Agree 98.5%,
    Disagree 1.5%
    Agenda No.1:
    Approval of financial statements
    Agree 98.8%,
    Disagree 1.2%
    Agenda No.2:
    Appointment of Executive Director
    (An Jae-hyeon)
    Agree 99.2%,
    Disagree 0.8%
    Agenda No.2:
    Appointment of Executive Director
    (Kim Eun-seon)
    Agree 99.2%,
    Disagree 0.8%
    Agenda No.2-1:
    Appointment of Executive Director
    (Jay Kim)
    Agree 97.1%,
    Disagree 2.9%
    Agenda No.3:
    Amendments to the Articles of Incorporation
    Agree 85.3%,
    Disagree 14.7%
    Agenda No.3:
    Amendments to the Articles of Incorporation
    Agree 99.7%,
    Disagree 0.3%
    Agenda No.2-2:
    Appointment of Executive Director
    (Daniel Chang)
    Agree 97.2%,
    Disagree 2.8%
    Agenda No.4:
    Granting of stock options
    Agree 91.3%,
    Disagree 8.7%
    Agenda No.4:
    Approval of Director Remuneration Limit
    Agree 93.3%,
    Disagree 6.7%
    Agenda No.2-3:
    Appointment of Executive Director
    (Kim Sung-jin)
    Agree 97.2%,
    Disagree 2.8%
    Agenda No.5:
    Approval of Director Remuneration Limit
    Agree 100% Agenda No.5:
    Approval of Auditor Remuneration Limit
    Agree 99.0%,
    Disagree 1.0%
    Agenda No.2-4: Appointment of Independent Director
    (Park Yun-sik)
    Agree 97.2%,
    Disagree 2.8%
    Agenda No.6:
    Approval of Auditor Remuneration Limit
    Agree 100% Agenda No.2-5:
    Appointment of Independent Director
    (Cha Tae-jin)
    Agree 97.2%,
    Disagree 2.8%
    Agenda No.3:
    Appointment of the Auditor
    (Lee Jae-sul)
    Agree 78.0%,
    Disagree 22.0%
    Agenda No.4:
    Amendments to the Articles of Incorporation
    Agree 99.3%,
    Disagree 0.7%
    Agenda No.5:
    Granting of stock options
    Agree 93.4%,
    Disagree 6.6%
    Agenda No.6:
    Approval of Director Remuneration Limit
    Agree 99.2%,
    Disagree 0.8%
    Agenda No.7:
    Approval of Auditor Remuneration Limit
    Agree 99.2%,
    Disagree 0.8%
  • Board of Directors

    Boryung’s Board of Directors (the “Board”) is currently composed of 4 Executive Directors and 2 Independent Directors.
    The Board leverages its expertise and skills in various fields to ensure efficient and strategic decision making.

    Board Composition

    As of March 25, 2022 (After the 58th Annual General Shareholders Meeting)

    Board Composition
    Name Positions Date of appointment Term Area of expertiese Liability insurance
    Jay Kim
    (Kim Jung-gyun)
    Chairman of the Board & CEO 2022.03.25 3 years Overall management Subscribed
    Daniel Chang
    (Chang Doo-hyun)
    CEO 2022.03.25 3 years Overall management Subscribed
    Kim Eun-seon Executive Director 2021.03.26 3 years Overall management Subscribed
    Kim Sung-jin Chief Strategy Officer 2022.03.25 3 years Overall management Subscribed
    Park Yun-sik Independent Director 2022.03.25 3 years Overall management Subscribed
    Cha Tae-jin Independent Director 2022.03.25 3 years Overall management Subscribed

    Board Committees

    As of June 30, 2022

    Board Committees
    Name Members Responsibilities
    Personnel Committee Kim Eun-seon
    Jay Kim (Kim Jung-gyun)
    Cha Tae-jin
    1. ① Matters concerning the limit of remuneration for Board of directors
    2. ② Matters concerning the evaluation of executives, performance compensation policies, and related internal regulations
    3. ③ Determination of details of the terms of the contract, etc. related to grant of stock options
    4. ④ Matters concerning the appointment and dismissal of managers, counselors, and advisors
    5. ⑤ Recommendation of candidates for independent directors
    6. ⑥ Other matters delegated by the Board of directors
    Investment Committee Jay Kim
    Kim Sung-jin
    Park Yun-sik
    1. ① Matters concerning investment of 5/100 or more of the total assets amount;
    2. ② Matters concerning investment of 5/100 or more of equity capital;
    3. ③ Matters concerning major investments that require changes to plans other than those reflected in annual/medium- and long-term management plans;
    4. ④ Other matters delegated by the Board of directors

    Activities

    Activities
    Date Agenda Results Executive Director Independent Director
    An Jae-hyeon
    (Attendance rate: 100%)
    Lee Sam-su
    (Attendance Rate: 100%)
    Kim Eun-seon
    (Attendance Rate: 100%)
    Daniel Chang
    (Attendance Rate: 100%)
    Park Yun-sik
    (Attendance Rate: 100%)
    Cheon In-gu
    (Attendance Rate: 100%)
    1 2021.02.25 Agenda No.1:
    Holding of the 57th Annual General Shareholders Meeting
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.2:
    Recommendation of director candidates
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.3:
    Decision on agenda for the 57th Annual General Shareholders Meeting
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.4:
    Implementation of the electronic voting
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.5:
    Approval of the health and safety plan
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.6:
    Extension of trust contract for acquiring treasury shares
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.7:
    Resolution on stock option evaluation
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.8:
    Approval of Related Party Transactions
    Approved Agree Agree Agree Agree Agree Agree
    2 2021.04.19 Agenda No.1:
    Contribution of the shares held by VIGENCELL to the employee’s stock ownership association
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.2:
    Extension of the term of overdrafts
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.3:
    Resolution on Seasoned Equity Offering
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.4:
    Resolution on Bonus Issue
    Approved Agree Agree Agree Agree Agree Agree
    3 2021.08.30 Agenda No.1:
    Appointment of CEO
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.2:
    Approval of LBA (Legacy Brands Acquisition)
    Approved Agree Agree Agree Agree Agree Agree
    4 2021.10.26 Agenda No.1:
    Change on person in charge of anti-bribery and compliance manager
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.2:
    Receipt of new loans for facilities
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.3:
    Receipt of new loans for facilities
    Approved Agree Agree Agree Agree Agree Agree
    5 2021.11.25 Agenda No.1:
    Report on management review of ISO37001 anti-bribery management system
    Approved Agree Agree Agree Agree Agree Agree
    6 2021.12.15 Agenda No.1:
    Investment in RECUON
    Approved Agree Agree Agree Agree Agree Agree
    Agenda No.2:
    Capital increase for Boryung Consumer Healthcare
    Approved Agree Agree Agree Agree Agree Agree
  • Audit Organization

    Boryung has established an audit organization under the direction and control of a full-time auditor to properly conduct internal audits and smoothly achieve audit objectives (hereinafter referred to as the audit team), and the independence of the full-time auditors and the audit team is ensured in accordance with the internal auditing guidelines in order to perform objective tasks.

    Audit

    Audit
    Title Name Date of appointment Terms Liability insurance
    Auditor Lee Jae-sul 2022.03.25 3 years Subscribed

    Independent Auditor

    Independent Auditor
    Name Date of appointment Contract terms Recent Result
    KPMG Samjong Accounting Corp. 2021.12.13 2022.01.01 ~ 2024.12.31 Unqualified Opinion
  • Key Indicators of Governance

    Boryung strives to establish a sound governance structure that upholds the rights and interests of shareholders and focuses on the interests and balance of stakeholders.

    Compliance of key indicators of governance

    Compliance of key indicators of governance
    Key indicators 2021
    Shareholders Send the convocation notice four weeks prior to the annual general shareholders meeting O
    Implement the electronic voting O
    Set the date for the annual general shareholders meeting to avoid a concentration period X
    Notify shareholders of the dividend policy and the dividend implementation plan at least once a year O
    Board of Directors Develop and implement a succession policy for CEO (including an emergency appointment policy) O
    Develop and operate internal control policy O
    Separate the Chairman of the Board and the CEO X
    Adopt a cumulative voting X
    Develop a policy to prevent corporate damages or violation of shareholders’ rights O
    Ensure that the term of appointment of an independent director not exceed six years O
    Audit Provide training for an internal auditor at least once a year X
    Establish an independent audit department (organization supporting a statutory auditor) O
    Assure the presence of accounting or financial experts in the audit O
    Hold a quarterly meeting of the independent auditors (held by the audit) without management O
    Allow auditors to access management-related information in the process O
TOP